Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Protalix_BioTherapeutics> ?p ?o. }
Showing items 1 to 65 of
65
with 100 items per page.
- Protalix_BioTherapeutics abstract "Protalix BioTherapeutics is an Israeli pharmaceutical company whose plant-based enzyme, taliglucerase alfa, has been approved by the U.S. Food and Drug Administration for the treatment of Gaucher disease.".
- Protalix_BioTherapeutics assets "1.1333E8".
- Protalix_BioTherapeutics foundingYear "1993".
- Protalix_BioTherapeutics industry Biotechnology.
- Protalix_BioTherapeutics keyPerson Chairman.
- Protalix_BioTherapeutics keyPerson Chief_executive_officer.
- Protalix_BioTherapeutics locationCity Karmiel.
- Protalix_BioTherapeutics locationCountry Israel.
- Protalix_BioTherapeutics numberOfEmployees "266".
- Protalix_BioTherapeutics product Taliglucerase_alfa.
- Protalix_BioTherapeutics revenue "1.151E7".
- Protalix_BioTherapeutics type Public_company.
- Protalix_BioTherapeutics wikiPageID "34371195".
- Protalix_BioTherapeutics wikiPageRevisionID "600951169".
- Protalix_BioTherapeutics assets "1.1333E8".
- Protalix_BioTherapeutics caption "Protalix logo".
- Protalix_BioTherapeutics founder "Yoseph Shaaltiel".
- Protalix_BioTherapeutics hasPhotoCollection Protalix_BioTherapeutics.
- Protalix_BioTherapeutics industry Biotechnology.
- Protalix_BioTherapeutics keyPeople "David Aviezer".
- Protalix_BioTherapeutics keyPeople "Zeev Bronfeld".
- Protalix_BioTherapeutics locationCity Karmiel.
- Protalix_BioTherapeutics locationCountry Israel.
- Protalix_BioTherapeutics logo File:Protalix_logo.jpg.
- Protalix_BioTherapeutics name "Protalix BioTherapeutics Inc.".
- Protalix_BioTherapeutics numEmployees "266".
- Protalix_BioTherapeutics products Taliglucerase_alfa.
- Protalix_BioTherapeutics revenue "1.151E7".
- Protalix_BioTherapeutics secCik "1006281".
- Protalix_BioTherapeutics symbol "PLX".
- Protalix_BioTherapeutics type Public_company.
- Protalix_BioTherapeutics subject Category:Biotechnology_companies_of_Israel.
- Protalix_BioTherapeutics subject Category:Companies_listed_on_TASE.
- Protalix_BioTherapeutics subject Category:Companies_listed_on_the_American_Stock_Exchange.
- Protalix_BioTherapeutics subject Category:Pharmaceutical_companies_established_in_1993.
- Protalix_BioTherapeutics subject Category:Pharmaceutical_companies_of_Israel.
- Protalix_BioTherapeutics type Abstraction100002137.
- Protalix_BioTherapeutics type BiotechnologyCompanies.
- Protalix_BioTherapeutics type BiotechnologyCompaniesOfIsrael.
- Protalix_BioTherapeutics type CompaniesEstablishedIn1993.
- Protalix_BioTherapeutics type CompaniesListedOnTASE.
- Protalix_BioTherapeutics type Company108058098.
- Protalix_BioTherapeutics type Group100031264.
- Protalix_BioTherapeutics type Institution108053576.
- Protalix_BioTherapeutics type Organization108008335.
- Protalix_BioTherapeutics type SocialGroup107950920.
- Protalix_BioTherapeutics type YagoLegalActor.
- Protalix_BioTherapeutics type YagoLegalActorGeo.
- Protalix_BioTherapeutics type YagoPermanentlyLocatedEntity.
- Protalix_BioTherapeutics type Agent.
- Protalix_BioTherapeutics type Company.
- Protalix_BioTherapeutics type Organisation.
- Protalix_BioTherapeutics type Organization.
- Protalix_BioTherapeutics type Agent.
- Protalix_BioTherapeutics type SocialPerson.
- Protalix_BioTherapeutics type Thing.
- Protalix_BioTherapeutics comment "Protalix BioTherapeutics is an Israeli pharmaceutical company whose plant-based enzyme, taliglucerase alfa, has been approved by the U.S. Food and Drug Administration for the treatment of Gaucher disease.".
- Protalix_BioTherapeutics label "Protalix BioTherapeutics".
- Protalix_BioTherapeutics sameAs m.03p3q9n.
- Protalix_BioTherapeutics sameAs Q7251166.
- Protalix_BioTherapeutics sameAs Q7251166.
- Protalix_BioTherapeutics sameAs Protalix_BioTherapeutics.
- Protalix_BioTherapeutics wasDerivedFrom Protalix_BioTherapeutics?oldid=600951169.
- Protalix_BioTherapeutics isPrimaryTopicOf Protalix_BioTherapeutics.
- Protalix_BioTherapeutics name "Protalix BioTherapeutics Inc.".
